Pharmavan Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 7

Pharmavan General Information

Description

Developer of cardiovascular drugs. The company develops drug molecular screening technologies and has drugs on clinical trail 2 and clinical trail 1, providing patients with innovative drugs to treat their diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Corporate Office
  • 5th Floor, Building 7, Zone C, Dongfang Industrial Park
  • No. 1, Huayun Road, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512 0000 0000

Pharmavan Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmavan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. IPO 06-Feb-2023 Cancelled Generating Revenue
12. Later Stage VC 29-Dec-2021 000.00 000.00 00000 Completed Generating Revenue
11. Later Stage VC 20-Apr-2021 00.000 000.00 00000 Completed Generating Revenue
10. Later Stage VC 01-Dec-2020 00.000 000.00 00000 Completed Generating Revenue
9. Later Stage VC 08-Jun-2020 00.000 000.00 0000 Completed Generating Revenue
8. Later Stage VC 13-Nov-2019 00.000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 26-Feb-2019 00.000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 06-Sep-2018 00.000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 05-Jul-2017 $4.7M $8.64M 000.00 Completed Generating Revenue
4. Later Stage VC 19-Jan-2017 $1.33M $3.94M 000.00 Completed Generating Revenue
To view Pharmavan’s complete valuation and funding history, request access »

Pharmavan Patents

Pharmavan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11602514-B2 Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof Active 28-Jul-2018 0000000000 0
EP-3756660-A4 Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof Pending 28-Jul-2018 0000000000 0
EP-3756660-A1 Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof Pending 28-Jul-2018 0000000000
US-20210015780-A1 Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof Active 28-Jul-2018 0000000000
JP-2022089845-A Drugs with anti-inflammatory bowel disease, their preparation methods and uses Pending 28-Jul-2018 C07C69/157 0
To view Pharmavan’s complete patent history, request access »

Pharmavan Executive Team (1)

Name Title Board Seat Contact Info
Yunsen Li Ph.D Chairman & Chief Executive Officer
To view Pharmavan’s complete executive team members history, request access »

Pharmavan Board Members (1)

Name Representing Role Since
Yunsen Li Ph.D Pharmavan Chairman & Chief Executive Officer 000 0000
To view Pharmavan’s complete board members history, request access »

Pharmavan Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmavan Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Junrun Capital Venture Capital Minority 000 0000 000000 0
Guolian Investment Corporate Venture Capital Minority 000 0000 000000 0
HaiBang Ventures Venture Capital Minority 000 0000 000000 0
Wuhan Tongji Modern Pharmaceutical Corporation Minority 000 0000 000000 0
Shenzhen Sangel Venture Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Pharmavan FAQs

  • When was Pharmavan founded?

    Pharmavan was founded in 2008.

  • Who is the CEO of Pharmavan?

    Yunsen Li Ph.D is the CEO of Pharmavan.

  • Where is Pharmavan headquartered?

    Pharmavan is headquartered in Suzhou, China.

  • What is the size of Pharmavan?

    Pharmavan has 47 total employees.

  • What industry is Pharmavan in?

    Pharmavan’s primary industry is Drug Discovery.

  • Is Pharmavan a private or public company?

    Pharmavan is a Private company.

  • What is Pharmavan’s current revenue?

    The current revenue for Pharmavan is 00000.

  • How much funding has Pharmavan raised over time?

    Pharmavan has raised $49.5M.

  • Who are Pharmavan’s investors?

    Junrun Capital, Guolian Investment, HaiBang Ventures, Wuhan Tongji Modern Pharmaceutical, and Shenzhen Sangel Venture Capital are 5 of 7 investors who have invested in Pharmavan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »